Skip to main content
S

SCL Science Inc. — Investor Relations & Filings

Ticker · 246960 ISIN · KR7246960009 KO Professional, scientific and technical activities
Open in API
Filings indexed 309 across all filing types
Latest filing 2024-12-30 Regulatory Filings
Country KR South Korea
Listing KO 246960

About SCL Science Inc.

https://sclscience.com/en

SCL Science Inc., formerly InnoTherapy Inc., is a healthcare company focused on digital innovation and advanced medical technologies. The company develops and commercializes medical hemostatic agents based on its proprietary biomimetic technology, including the Bio-inspired Medical Materials (BiMM) product line. Leveraging 40 years of expertise in medical science, SCL Science is also dedicated to building a digital healthcare ecosystem using artificial intelligence and high-quality medical data. Its services extend to clinical trial analysis, bio-logistics, and an expanding drug discovery platform focused on AI-driven cancer vaccine development. The company serves hospitals, research laboratories, and other medical institutions.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory notice regarding the setting of a record date for a shareholder meeting (specifically an Extraordinary General Meeting). It does not contain the full proxy materials or the meeting results themselves, but rather serves as a formal regulatory announcement of the record date. Given the nature of the filing as a standard regulatory disclosure regarding corporate actions, it fits best under the RNS (Regulatory Filings) category.
2024-12-30 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) from a South Korean company, SCL Science, detailing the decision to issue convertible bonds (전환사채권 발행결정). This type of filing is a standard regulatory disclosure in the Korean market (DART system) regarding capital structure changes and financing activities. Since it specifically details the issuance of new convertible bonds, it falls under the 'Capital/Financing Update' category.
2024-12-30 Korean
주주총회소집결의 (임시주주총회)
AGM Information Classification · 1% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for SCL Science, detailing the date, location, and agenda items (specifically a stock exchange agreement). This type of document is a standard proxy solicitation or meeting notice sent to shareholders to inform them of upcoming votes, which falls under the Proxy Solicitation & Information Statement category.
2024-12-30 Korean
주권매매거래정지해제 (우회상장 미해당)
Delisting Announcement Classification · 1% confidence The document is a short regulatory notice regarding the lifting of a trading suspension for a specific company (SCL Science) on the KOSDAQ market. It cites specific exchange regulations and provides the effective date for the resumption of trading. Since it is a regulatory announcement regarding market status rather than a financial report, dividend, or corporate action, it falls under the general regulatory filings category.
2024-12-30 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the procedural steps for the meeting. Given the nature of the announcement as a regulatory disclosure of corporate action, it fits best under the RNS category.
2024-12-18 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 에스씨엘사이언스' covering the period from January 1, 2024, to September 30, 2024. It contains detailed corporate information, financial data, and management disclosures typical of a formal quarterly filing submitted to the Financial Supervisory Service (FSS) and the Korea Exchange. It is not an announcement of a report, but the report itself, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.